Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 135 articles:
HTML format
Text format



Single Articles


    September 2018
  1. KRASNODEBSKI M, Grat M, Stypulkowski J, Bik E, et al
    Impact of Donor Risk Index on Risk of Hepatic Artery Thrombosis in Patients After Orthotopic Liver Transplantation.
    Transplant Proc. 2018;50:2006-2008.
    PubMed     Text format     Abstract available


  2. GRAT K, Grat M, Rowinski O, Patkowski W, et al
    Accuracy of Computed Tomography in the Assessment of Milan Criteria in Liver Transplantation for Hepatocellular Carcinoma.
    Transplant Proc. 2018;50:2002-2005.
    PubMed     Text format     Abstract available


    July 2018
  3. WSZOLA M, Berman A, Ostaszewska A, Gorski L, et al
    Islets Allotransplantation Into Gastric Submucosa in a Patient with Portal Hypertension: 4-year Follow-up.
    Transplant Proc. 2018;50:1910-1913.
    PubMed     Text format     Abstract available


    June 2018
  4. ITO R, Ito M, Asano Y, Murakumo A, et al
    Availability of a Magnetic Method for Hepatocyte Transplantation.
    Transplant Proc. 2018;50:1525-1531.
    PubMed     Text format     Abstract available


  5. HE Q, Jiang JJ, Jiang YX, Wang WT, et al
    Health-Related Quality of Life Comparisons After Radical Therapy for Early-Stage Hepatocellular Carcinoma.
    Transplant Proc. 2018;50:1470-1474.
    PubMed     Text format     Abstract available


  6. GOTO Y, Shirahama N, Sasaki S, Kawahara R, et al
    Endovascular Treatment for Very Early Hepatic Artery Stenosis Following Living-Donor Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2018;50:1457-1460.
    PubMed     Text format     Abstract available


  7. PAVEL MC, Sanchez Cabus S, Crespo G, Ferrer J, et al
    Role of Adult Living Donor Liver Transplantation in the Treatment of Hepatocellular Carcinoma Within and Beyond Milan Criteria: A Comparative Study.
    Transplant Proc. 2018;50:1386-1395.
    PubMed     Text format     Abstract available


  8. MEHTA NN, Mangla V, Varma V, Lalwani S, et al
    Minimizing Hepatic Artery Thrombosis and Establishing Safety of Grafts With Dual Arteries in Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:1378-1385.
    PubMed     Text format     Abstract available


  9. PAI SL, Aniskevich S 3rd, Logvinov II, Matcha GV, et al
    Hypertrophic Cardiomyopathy in Liver Transplantation Patients.
    Transplant Proc. 2018;50:1466-1469.
    PubMed     Text format     Abstract available


  10. COELHO GR, Praciano AM, Viana GNR, Lima CA, et al
    Outcomes of Liver Transplant Recipients With Model for End-Stage Liver Disease Exception: Single-Center Experience in the Northeast of Brazil.
    Transplant Proc. 2018;50:1428-1430.
    PubMed     Text format     Abstract available


  11. ERSHOFF BD, Gordin JS, Vorobiof G, Elashoff D, et al
    Improving the Prediction of Mortality in the High Model for End-Stage Liver Disease Score Liver Transplant Recipient: A Role for the Left Atrial Volume Index.
    Transplant Proc. 2018;50:1407-1412.
    PubMed     Text format     Abstract available


    May 2018
  12. JUNRUNGSEE S, Lapisatepun W, Chotirosniramit A, Sandhu T, et al
    How to Reconstruct Middle Hepatic Vein Branches With Explanted Portal Vein and Inferior Mesenteric Vein Graft: A Case Report.
    Transplant Proc. 2018;50:1202-1204.
    PubMed     Text format     Abstract available


  13. MA KW, Chan ACY, She BWH, Chok KSH, et al
    Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation.
    Transplant Proc. 2018;50:1087-1093.
    PubMed     Text format     Abstract available


  14. YAGI T, Takagi K, Yoshida R, Umeda Y, et al
    New Left Lobe Transplantation Procedure with Caval Reconstruction Using an Inverted Composite Graft for Chronic Budd-Chiari Syndrome in Living-Donor Liver Transplantation-A Case Report.
    Transplant Proc. 2018;50:1192-1195.
    PubMed     Text format     Abstract available


  15. KIM YJ, Yoon JH, Kim SI, Choi HJ, et al
    Impact of Pretransplant Infections on Clinical Course in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1153-1156.
    PubMed     Text format     Abstract available


  16. PARK PJ, Yu YD, Yoon YI, Kim SR, et al
    Single-Center Experience Using Marginal Liver Grafts in Korea.
    Transplant Proc. 2018;50:1147-1152.
    PubMed     Text format     Abstract available


  17. ELSHOUBARY M, Shehta A, Salah T, Sultan AM, et al
    Predictive Factors of Liver Dysfunction After Right Hemihepatectomy for Adult Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:1114-1122.
    PubMed     Text format     Abstract available


  18. KWON HM, Moon YJ, Jung KW, Jun IG, et al
    Pretransplantation Cystatin C, but not Creatinine, Predicts 30-day Cardiovascular Events and Mortality in Liver Transplant Recipients With Normal Serum Creatinine Levels.
    Transplant Proc. 2018;50:1094-1099.
    PubMed     Text format     Abstract available


    April 2018
  19. OKADA N, Sanada Y, Urahashi T, Ihara Y, et al
    Endotoxin Metabolism Reflects Hepatic Functional Reserve in End-Stage Liver Disease.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30210.
    PubMed     Text format     Abstract available


  20. PURI Y, Srinivasan P, Peddu P, Heaton N, et al
    Case Report of Multiple Bilobar Hepatic Arterio-Portal Fistulas Post-Liver Transplantation Managed Conservatively.
    Transplant Proc. 2018;50:920-924.
    PubMed     Text format     Abstract available


  21. TARTARO RR, Jorge GL, Dianin AH, Escanhoela CAF, et al
    Ischemia With Preconditioning in Wistar Rats Maintains Mitochondrial Respiration, Even With Mild Hepatocellular Disturbance.
    Transplant Proc. 2018;50:848-852.
    PubMed     Text format     Abstract available


  22. DE ALMEIDA TN, Victorino JP, Bistafa Liu J, Tofoli Queiroz Campos D, et al
    Effect of Hepatic Preconditioning with the Use of Methylene Blue on the Liver of Wistar Rats Submitted to Ischemia and Reperfusion.
    Transplant Proc. 2018;50:841-847.
    PubMed     Text format     Abstract available


  23. DUARTE RP, da Silva AMO, Tonella RM, Ratti LSR, et al
    Model for End-Stage Liver Disease Score Before Hepatic Transplantation and Root Mean Square of the Diaphragmatic Domes Affect Postoperative Extubation Time.
    Transplant Proc. 2018;50:776-778.
    PubMed     Text format     Abstract available


  24. NASCIMENTO SV, Gonzalez AM, Aguiar Roza B, Pimentel CFMG, et al
    Development of Routine Dental Care for Liver Transplant Outpatients.
    Transplant Proc. 2018;50:779-783.
    PubMed     Text format     Abstract available


  25. NACIF LS, Pinheiro RS, Rocha-Santos V, Barbosa VM, et al
    Better Selection Criteria With Prognostic Factors for Liver Transplantation.
    Transplant Proc. 2018;50:766-768.
    PubMed     Text format     Abstract available


  26. ROQUE L, Sankarankutty AK, Silva OC Jr., Mente ED, et al
    Evaluation of Lung Function in Liver Transplant Candidates.
    Transplant Proc. 2018;50:762-765.
    PubMed     Text format     Abstract available


  27. MARTINO RB, Waisberg DR, Dias APM, Inoue VBS, et al
    Access to Liver Transplantation in Different ABO-Blood Groups and "Exceptions Points" in a Model for End-Stage Liver Disease Allocation System: A Brazilian Single-Center Study.
    Transplant Proc. 2018;50:754-757.
    PubMed     Text format     Abstract available


  28. TEH YE, Ang MLT, La MV, Gunalan V, et al
    Donor-Derived Candida dubliniensis Resulting in Perigraft Abscesses in a Liver Transplant Recipient Proven by Whole Genome Sequencing: A Case Report.
    Transplant Proc. 2018;50:915-919.
    PubMed     Text format     Abstract available


  29. JUNG BH, Park JI, Lee SG
    Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report.
    Transplant Proc. 2018;50:910-914.
    PubMed     Text format     Abstract available


    March 2018
  30. TENORIO GONZALEZ E, Robles Diaz M, Sanjuan Jimenez R, Gonzalez Grande R, et al
    Retransplant Due to Fulminant Hepatic Failure From Hepatitis E Virus: A Case Report.
    Transplant Proc. 2018;50:685-686.
    PubMed     Text format     Abstract available


  31. RUIZ DE AZUA-LOPEZ Z, Naranjo-Izurieta JR, Lameirao J, Martin-Villen L, et al
    Cold Ischemia Time as a Factor in Post-transplantation Complications for Orthotopic Hepatic Transplantation.
    Transplant Proc. 2018;50:637-639.
    PubMed     Text format     Abstract available


  32. SANCHEZ-LORENCIO MI, Saenz L, Ramirez P, Villalba-Lopez F, et al
    Matrix Metalloproteinase 1 as a Novel Biomarker for Monitoring Hepatocellular Carcinoma in Liver Transplant Patients.
    Transplant Proc. 2018;50:623-627.
    PubMed     Text format     Abstract available


  33. VALVERDE-LOPEZ F, Angeles Lopez Garrido M, Ortega-Suazo EJ, Vadillo-Calles F, et al
    Results of 15-Year Experience in Liver Transplant for Hepatocellular Carcinoma.
    Transplant Proc. 2018;50:617-618.
    PubMed     Text format     Abstract available


  34. CASCALES-CAMPOS P, Martinez-Insfran LA, Ramirez P, Ferreras D, et al
    Liver Transplantation in Patients With Hepatocellular Carcinoma Outside the Milan Criteria After Downstaging: Is It Worth It?
    Transplant Proc. 2018;50:591-594.
    PubMed     Text format     Abstract available


  35. PRIETO AMORIN J, Lopez M, Rando K, Castelli J, et al
    Early Bacterial Pneumonia After Hepatic Transplantation: Epidemiologic Profile.
    Transplant Proc. 2018;50:503-508.
    PubMed     Text format     Abstract available


  36. CAICEDO LA, Delgado A, Duque M, Jimenez DF, et al
    Tumor Biology as Predictor of Mortality in Liver Transplantation for Hepatocellular Carcinoma.
    Transplant Proc. 2018;50:485-492.
    PubMed     Text format     Abstract available


  37. DOMINGUEZ BASTANTE M, Molina Raya A, Vilchez Rabelo A, Villar Del Moral J, et al
    Analysis of Ischemic Cholangiopathy After Treatment of Arterial Thrombosis in Liver Transplantation in Our Series.
    Transplant Proc. 2018;50:628-630.
    PubMed     Text format     Abstract available


  38. OLMEDO-MARTIN RV, Amo-Trillo V, Gonzalez-Grande R, Tenorio-Gonzalez E, et al
    Efficacy and Safety of Anti-TNF-alpha Agents in Inflammatory Bowel Disease After Liver Transplant: A Case Series.
    Transplant Proc. 2018;50:619-622.
    PubMed     Text format     Abstract available


  39. DIOS-BARBEITO S, Dominguez-Bastante M, Moreno-Navas A, Leon-Diaz FJ, et al
    Multicentric Study of the Andalusian Experience in Polycystic Liver Disease as Indication for Liver Transplantation.
    Transplant Proc. 2018;50:613-616.
    PubMed     Text format     Abstract available


  40. TRIGUERO CABRERA J, Zambudio Carroll N, Gonzalez Martinez S, Villar Quintana R, et al
    Analysis of Indications and Results in Liver Retransplantation: Is Late Retransplantation Worthwhile?
    Transplant Proc. 2018;50:598-600.
    PubMed     Text format     Abstract available


  41. GONZALEZ MARTINEZ S, Molina Raya A, Becerra Massare A, Muffak Granero K, et al
    Liver Transplantation in Recipients With High Model for End-stage Liver Disease Score.
    Transplant Proc. 2018;50:595-597.
    PubMed     Text format     Abstract available


  42. OLIVARI D, Mainardi V, Rando K, Rey G, et al
    Risk Factors of Mortality After Liver Transplantation in Uruguay.
    Transplant Proc. 2018;50:499-502.
    PubMed     Text format     Abstract available


  43. HADDAD L, Marciano S, Cleres M, Zerega A, et al
    Characteristics of Liver Transplantation in Argentina: A Multicenter Study.
    Transplant Proc. 2018;50:478-484.
    PubMed     Text format     Abstract available


  44. DE ATAIDE EC, Reges Perales S, de Oliveira Peres MA, Bastos Eloy da Costa L, et al
    Acute Liver Failure Induced by Carthamus tinctorius Oil: Case Reports and Literature Review.
    Transplant Proc. 2018;50:476-477.
    PubMed     Text format     Abstract available


  45. DE ATAIDE EC, Reges Perales S, Bastos Eloy da Costa L, Valerini FG, et al
    Acute Liver Failure-25 Years at a Single Center: Role of Liver Transplantation in the Survival of Adult Patients.
    Transplant Proc. 2018;50:472-475.
    PubMed     Text format     Abstract available


  46. MAINARDI V, Rando K, Olivari D, Rey G, et al
    Mortality Analysis of Acute Liver Failure in Uruguay.
    Transplant Proc. 2018;50:465-471.
    PubMed     Text format     Abstract available


  47. DACIUK NI, Quinonez EG, Poupard M, Vergara Sandoval RM, et al
    Access to Grafts in a Liver Transplant Center: Does It Rely on the Severity of the Waiting List Population?
    Transplant Proc. 2018;50:387-390.
    PubMed     Text format     Abstract available


    January 2018
  48. TANG JX, Na N, Li JJ, Fan L, et al
    Outcomes of Controlled Donation After Cardiac Death Compared With Donation After Brain Death in Liver Transplantation: A Systematic Review and Meta-analysis.
    Transplant Proc. 2018;50:33-41.
    PubMed     Text format     Abstract available


  49. WANG W, Xiao Q, Hu XY, Liu ZZ, et al
    Mild Hypothermia Pretreatment Attenuates Liver Ischemia Reperfusion Injury Through Inhibiting c-Jun NH2-terminal Kinase Phosphorylation in Rats.
    Transplant Proc. 2018;50:259-266.
    PubMed     Text format     Abstract available


  50. KIESLICHOVA E, Frankova S, Protus M, Merta D, et al
    Acute Liver Failure due to Amanita phalloides Poisoning: Therapeutic Approach and Outcome.
    Transplant Proc. 2018;50:192-197.
    PubMed     Text format     Abstract available


    December 2017
  51. HONG SY, Kim BW, Wang HJ, Kim IG, et al
    Hanging Hepato-Atrial Anastomosis in Deceased-Donor Liver Transplantation for Budd-Chiari Syndrome With Extensive Vena Cava Obliteration: A Case Report.
    Transplant Proc. 2017;49:2395-2398.
    PubMed     Text format     Abstract available


  52. MUNAWAR K, Rajagopalan N, Grigorian A, Dennis D, et al
    Successful Liver Transplantation From a Donor With a Continuous-Flow Left Ventricular Assist Device for 9 Months.
    Transplant Proc. 2017;49:2406-2408.
    PubMed     Text format     Abstract available


  53. PAREKH A, Rajaram P, Patel G, Subramanian RM, et al
    Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:2399-2401.
    PubMed     Text format     Abstract available


  54. CAN MG, Ozer A, Iyigun M, Gokay BV, et al
    Takotsubo Cardiomyopathy Resulting in Cardiac Arrest in a Patient Undergoing Liver Transplantation.
    Transplant Proc. 2017;49:2392-2394.
    PubMed     Text format     Abstract available


    November 2017
  55. JEONG JS, Kim D, Kim KY, Ryu S, et al
    Ischemic Preconditioning Produces Comparable Protection Against Hepatic Ischemia/Reperfusion Injury Under Isoflurane and Sevoflurane Anesthesia in Rats.
    Transplant Proc. 2017;49:2188-2193.
    PubMed     Text format     Abstract available


  56. GAMBARO SE, Romero P, Pedraza N, Moulin L, et al
    Right Extended Split Liver Transplantation Compared With Whole Liver Transplantation: Lessons Learned at a Single Center in Latin America-Results From a Match Case-Control Study.
    Transplant Proc. 2017;49:2122-2128.
    PubMed     Text format     Abstract available


    October 2017
  57. BALOGH J, Gordon-Burroughs S, Schwarz P, Galati J, et al
    Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm.
    Transplant Proc. 2017;49:1864-1869.
    PubMed     Text format     Abstract available


  58. PANG NQ, Kow WCA, Law JH, Pan LTT, et al
    Role of Coronary Angiography in Pre-Liver Transplantation Cardiac Evaluation: Experience From an Asian Transplant Institution.
    Transplant Proc. 2017;49:1797-1805.
    PubMed     Text format     Abstract available


  59. KARACA C, Yilmaz C, Ferecov R, Iakobadze Z, et al
    Living-Donor Liver Transplantation for Budd-Chiari Syndrome: Case Series.
    Transplant Proc. 2017;49:1841-1847.
    PubMed     Text format     Abstract available


  60. AKTAS H, Ozer A, Guner OS, Gurluler E, et al
    Liver Transplantation in Patients With Complete Portal Vein Thrombosis: Renoportal or Varicoportal Anastomosis Using Cryopreserved Vein Grafts.
    Transplant Proc. 2017;49:1820-1823.
    PubMed     Text format     Abstract available


  61. CHUNG IS, Jee HS, Han S, Ko JS, et al
    Effect of Prereperfusion Ephedrine on Postreperfusion Syndrome and Graft Function in Living Donor Liver Transplantation.
    Transplant Proc. 2017;49:1815-1819.
    PubMed     Text format     Abstract available


    September 2017
  62. ALIYEV V, Yasuchika K, Hammad A, Badawy A, et al
    Coexistent End-stage Nonalcoholic Steatohepatitis and Colon Cancer: Should We Do Liver Transplantation?
    Transplant Proc. 2017;49:1649-1651.
    PubMed     Text format     Abstract available


  63. PRUSINSKAS B, Kathemann S, Pilic D, Hegen B, et al
    Cholestasis After Pediatric Liver Transplantation-Recurrence of a Progressive Familial Intrahepatic Cholestasis Phenotype as a Rare Differential Diagnosis: A Case Report.
    Transplant Proc. 2017;49:1628-1633.
    PubMed     Text format     Abstract available


  64. LUO Y, Zhao D, Zhang M, Zhou T, et al
    Hepatic Artery Reconstruction Using 3-in-1 Segmental Resection in Pediatric Living Donor Liver Transplantation: A Case Report and Literature Review.
    Transplant Proc. 2017;49:1619-1623.
    PubMed     Text format     Abstract available


  65. KORDA D, Deak PA, Kiss G, Gerlei Z, et al
    Management of Portal Hypertension After Liver Transplantation.
    Transplant Proc. 2017;49:1530-1534.
    PubMed     Text format     Abstract available


  66. NAKASEKO Y, Shiba H, Yamanouchi E, Takano Y, et al
    Successful Treatment of Stricture of Duct-to-Duct Biliary Anastomosis After Living-Donor Liver Transplantation of the Left Lobe: A Case Report.
    Transplant Proc. 2017;49:1644-1648.
    PubMed     Text format     Abstract available


  67. EDGERTON CA, McGillicuddy JW, DuBay D, Nadig SN, et al
    Utilization of the Iliac Artery as Inflow in the Morbidly Obese During Orthotopic Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1624-1627.
    PubMed     Text format     Abstract available


  68. WAKASA Y, Kudo D, Ishido K, Kimura N, et al
    Living-Donor Liver Transplantation With the Use of a Left-Lobe Graft From a Donor With Anomalous Biliary Anatomy in Which B4 Joins the Right Anterior Sectional Duct: A Case Report.
    Transplant Proc. 2017;49:1615-1618.
    PubMed     Text format     Abstract available


  69. KURATA N, Onishi Y, Kamei H, Hori T, et al
    Successful Blood Transfusion Management of a Living Donor Liver Transplant Recipient in the Presence of Anti-Jra: A Case Report.
    Transplant Proc. 2017;49:1604-1607.
    PubMed     Text format     Abstract available


    July 2017
  70. ZHAO Z, Leow WQ
    Concurrent Hepatic Tuberculosis and Hepatic Graft-versus-host Disease in an Allogeneic Hematopoietic Stem Cell Transplant Recipient: A Case Report.
    Transplant Proc. 2017 Jul 31. pii: S0041-1345(17)30293.
    PubMed     Text format     Abstract available


  71. RONG YP, Huang HT, Liu JS, Wei L, et al
    Protective Effects of Geniposide on Hepatic Ischemia/Reperfusion Injury.
    Transplant Proc. 2017;49:1455-1460.
    PubMed     Text format     Abstract available


  72. YOU DD, Choi GS, Kim JM, Kwon CHD, et al
    Long-term Outcomes for Liver Transplant Recipients in Terms of Hepatic Encephalopathy.
    Transplant Proc. 2017;49:1425-1429.
    PubMed     Text format     Abstract available


  73. ELKHOLY S, Mogawer S, Hosny A, El-Shazli M, et al
    Predictors of Mortality in Living Donor Liver Transplantation.
    Transplant Proc. 2017;49:1376-1382.
    PubMed     Text format     Abstract available


  74. KRESPI MR, Tankurt A, Acarli K, Kanmaz T, et al
    Beliefs of Living Donors About Recipients' End-Stage Liver Failure and Surgery for Organ Donation.
    Transplant Proc. 2017;49:1369-1375.
    PubMed     Text format     Abstract available


  75. STANKIEWICZ R, Kornasiewicz O, Grat M, Lewandowski Z, et al
    Is Elective Status a Predictor of Poor Survival in Liver Retransplantation?
    Transplant Proc. 2017;49:1364-1368.
    PubMed     Text format     Abstract available


  76. YANG L, Xin EY, Liao B, Lai LJ, et al
    Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Transplant Proc. 2017;49:1357-1363.
    PubMed     Text format     Abstract available


  77. BAEK SD, Jang M, Kim W, Yu H, et al
    Benefits of Intraoperative Continuous Renal Replacement Therapy During Liver Transplantation in Patients With Renal Dysfunction.
    Transplant Proc. 2017;49:1344-1350.
    PubMed     Text format     Abstract available


    June 2017
  78. KO HM, Joo SH, Jo JH, Park WS, et al
    Liver-Wrapping, Nitric Oxide-Releasing Nanofiber Downregulates Cleaved Caspase-3 and Bax Expression on Rat Hepatic Ischemia-Reperfusion Injury.
    Transplant Proc. 2017;49:1170-1174.
    PubMed     Text format     Abstract available


  79. TOKODAI K, Kawagishi N, Miyagi S, Nakanishi C, et al
    Splenectomy for Severe Intestinal Bleeding Caused by Portal Hypertensive Enteropathy After Pediatric Living-Donor Liver Transplantation: A Report of Three Cases.
    Transplant Proc. 2017;49:1129-1132.
    PubMed     Text format     Abstract available


  80. OYA Y, Sugawara Y, Honda M, Yoshii D, et al
    Living Donor Liver Transplantation for Progressive Familial Intrahepatic Cholestasis Type 1: Two Reported Cases.
    Transplant Proc. 2017;49:1123-1125.
    PubMed     Text format     Abstract available


  81. KIM TS, Kim JM, Kwon CHD, Kim SJ, et al
    Prognostic Factors Predicting Poor Outcome in Living-Donor Liver Transplantation for Fulminant Hepatic Failure.
    Transplant Proc. 2017;49:1118-1122.
    PubMed     Text format     Abstract available


  82. KOSITAMONGKOL P, Sanphasitvong V, Sirivatanauksorn Y, Pongpaibul A, et al
    Outcome of Liver Transplantation in Hepatocellular Carcinoma Patients at Siriraj Hospital.
    Transplant Proc. 2017;49:1114-1117.
    PubMed     Text format     Abstract available


  83. PARK MS, Lee KW, Kim H, Choi YR, et al
    Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma.
    Transplant Proc. 2017;49:1109-1113.
    PubMed     Text format     Abstract available


  84. PARK MS, Lee KW, Kim H, Choi YR, et al
    Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology.
    Transplant Proc. 2017;49:1103-1108.
    PubMed     Text format     Abstract available


  85. NAGATSU A, Yoshizumi T, Ikegami T, Harimoto N, et al
    In Situ Posterior Graft Segmentectomy for Large-for-Size Syndrome in Deceased Donor Liver Transplantation in Adults: A Case Report.
    Transplant Proc. 2017;49:1199-1201.
    PubMed     Text format     Abstract available


  86. PARK JI, Jung BH, Lee SG
    Veno-Arterial-Venous Hybrid Mode of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome Combined With Septic Shock in a Liver Transplant Patient: A Case Report.
    Transplant Proc. 2017;49:1192-1195.
    PubMed     Text format     Abstract available


  87. SASAKI K, Sakamoto S, Uchida H, Narumoto S, et al
    Liver Transplantation for Mitochondrial Respiratory Chain Disorder: A Single-Center Experience and Excellent Marker of Differential Diagnosis.
    Transplant Proc. 2017;49:1097-1102.
    PubMed     Text format     Abstract available


  88. KWON HM, Jun IG, Jung KW, Moon YJ, et al
    Pretransplant Resting Heart Rate and Its Association With All-Cause Mortality in Liver Transplant Recipients.
    Transplant Proc. 2017;49:1092-1096.
    PubMed     Text format     Abstract available


  89. KIM SH, Moon YJ, Kim JW, Song JG, et al
    Prediction of Fluid Responsiveness by a Non-invasive Respiratory Systolic Time Interval Variation Using Heart Sound Signals in Recipients Undergoing Liver Transplantation.
    Transplant Proc. 2017;49:1082-1086.
    PubMed     Text format     Abstract available


  90. JEONG HW, Kwon HM, Jung KW, Moon YJ, et al
    Does Activated Clotting Time Help to Predict Innate Coagulopathy in End-Stage Liver Disease Patients?
    Transplant Proc. 2017;49:1076-1081.
    PubMed     Text format     Abstract available


    May 2017
  91. DE LOURDES JORGE G, Dos Reis Tartaro R, Fazzio Escanhoela CA, Boin IFSF, et al
    Later Evaluation of Ischemia and Reperfusion by the Pringle Maneuver in Wistar Rats, Demonstrating That Hepatic Lesions Can Be Reversible.
    Transplant Proc. 2017;49:898-901.
    PubMed     Text format     Abstract available


  92. PULITI REIGADA CH, de Ataide EC, de Almeida Prado Mattosinho T, Boin IFSF, et al
    Hepatic Artery Thrombosis After Liver Transplantation: Five-Year Experience at the State University of Campinas.
    Transplant Proc. 2017;49:867-870.
    PubMed     Text format     Abstract available


  93. BINA POSSATTO M, de Ataide EC, Fazzio Escanhoela CA, Seva-Pereira T, et al
    Factors Related to Hepatocellular Carcinoma Recurrence After Liver Transplantation-A Brazilian Multicenter Study.
    Transplant Proc. 2017;49:863-866.
    PubMed     Text format     Abstract available


  94. ATAIDE EC, Perales SR, Silva MG, Filho FC, et al
    Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.
    Transplant Proc. 2017;49:858-862.
    PubMed     Text format     Abstract available


  95. LAUER SS, Miguel GPS, de Abreu IW, Stein AB, et al
    Hepatic Transplants in Espirito Santo State, Brazil.
    Transplant Proc. 2017;49:841-847.
    PubMed     Text format     Abstract available


  96. OSNI LEAO PERIN P, de Fatma Ferreira Santana Boin I, Oliveira da Silva AM, Chueiri Neto F, et al
    Lung Ultrasound and Pulmonary Function Test in Cirrhotic Patients.
    Transplant Proc. 2017;49:824-828.
    PubMed     Text format     Abstract available


  97. ZANUS G, Romano M, Finotti M, Dalla Bona E, et al
    Liver Retransplantation for Hepatic Abscess Due to Hepatic Artery Thrombosis: A Case Report.
    Transplant Proc. 2017;49:736-739.
    PubMed     Text format     Abstract available


  98. CIMA L, Riva G, D'Errico A, Casartelli-Liviero M, et al
    Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation.
    Transplant Proc. 2017;49:667-670.
    PubMed     Text format     Abstract available


  99. CHEDID MF, Bosi HR, Chedid AD, Alvares-da-Silva MR, et al
    One Hundred Consecutive Liver Transplants Using Institutes Georges Lopez-1 Preservation Solution: Outcomes and Prognostic Factors.
    Transplant Proc. 2017;49:848-851.
    PubMed     Text format     Abstract available


  100. EBOLI L, Tannuri AC, Gibelli N, Silva T, et al
    Comparison of the Results of Living Donor Liver Transplantation Due to Acute Liver Failure and Biliary Atresia in a Quaternary Center.
    Transplant Proc. 2017;49:832-835.
    PubMed     Text format     Abstract available


  101. ZAOUALI MA, Panisello A, Lopez A, Folch E, et al
    Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation.
    Transplant Proc. 2017;49:765-769.
    PubMed     Text format     Abstract available


    April 2017
  102. OZBILGIN M, Unek T, Egeli T, Agalar C, et al
    Hepatic Artery Reconstruction With Autologous Inferior Mesenteric Artery Graft in Living Donor Liver Transplant Recipients.
    Transplant Proc. 2017;49:566-570.
    PubMed     Text format     Abstract available


  103. OZDEMIR F, Ersan V, Baskiran A, Ince V, et al
    Surgical Treatment of Portal Vein Thrombosis With the Use of Cadaveric Venous Patch After Donor Hepatectomy: A Case Report.
    Transplant Proc. 2017;49:606-608.
    PubMed     Text format     Abstract available


  104. ACAR S, Gencdal G, Tokac M, Eren E, et al
    Liver Transplantation for Polycystic Liver Disease Due to Huge Liver With Related Complications: A Case Report.
    Transplant Proc. 2017;49:603-605.
    PubMed     Text format     Abstract available


  105. SARICI KB, Karakas S, Otan E, Ince V, et al
    Can Patients Who Develop Cerebral Death in Fulminant Liver Failure Despite Liver Transplantation Be Previously Forseen?
    Transplant Proc. 2017;49:571-574.
    PubMed     Text format     Abstract available


  106. UNEK T, Egeli T, Ozbilgin M, Celik A, et al
    Long-term Results of Living Donors in Simultaneous Kidney and Liver Transplantations.
    Transplant Proc. 2017;49:403-406.
    PubMed     Text format     Abstract available


    March 2017
  107. BOZSO SJ, Nagendran J, Gill RS, Freed DH, et al
    Impact of Obesity on Heart and Lung Transplantation: Does Pre-Transplant Obesity Affect Outcomes?
    Transplant Proc. 2017;49:344-347.
    PubMed     Text format     Abstract available


  108. RAJARAM P, Parekh A, Fisher M, Kempker J, et al
    Comparison of Post-Liver Transplantation Outcomes in Portopulmonary Hypertension and Pulmonary Venous Hypertension: A Single-Center Experience.
    Transplant Proc. 2017;49:338-343.
    PubMed     Text format     Abstract available


  109. HADDAD L, Andrade K, Mendes L, Ducatti L, et al
    Association Between Readmission After Liver Transplant and Adverse Immunosuppressant Reactions: A Prospective Cohort With a 1-Year Follow-up.
    Transplant Proc. 2017;49:330-337.
    PubMed     Text format     Abstract available


  110. WONG LL, Lacar L, Roytman M, Orloff SL, et al
    Urgent Liver Transplantation for Dietary Supplements: An Under-Recognized Problem.
    Transplant Proc. 2017;49:322-325.
    PubMed     Text format     Abstract available


    January 2017
  111. SHEN CH, Dong KR, Tao YF, Chen G, et al
    Liver Transplantation for Biliary Rhabdomyosarcoma With Liver Metastasis: Report of One Case.
    Transplant Proc. 2017;49:185-187.
    PubMed     Text format     Abstract available


  112. KIM K, Jeong DW, Lee YH, Kim YG, et al
    Everolimus-Induced Systemic Serositis After Simultaneous Liver and Kidney Transplantation: A Case Report.
    Transplant Proc. 2017;49:181-184.
    PubMed     Text format     Abstract available


  113. SOEJIMA Y, Yoshizumi T, Ikegami T, Harimoto N, et al
    In Situ Procurement of a Recipient's Portal Vein for a Right Lobe Liver Graft With Multiple Venous Orifices: A Case Report.
    Transplant Proc. 2017;49:172-174.
    PubMed     Text format     Abstract available


  114. NOGUCHI Y, Ueno T, Matsuura R, Kodama T, et al
    Liver Failure From Ultra-Short Bowel Syndrome on the Intestinal Transplant Waiting List: A Retrospective Study.
    Transplant Proc. 2017;49:135-138.
    PubMed     Text format     Abstract available


  115. RYU JH, Lee TB, Park YM, Yang KH, et al
    Pancreas Transplantation After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:225-228.
    PubMed     Text format     Abstract available


    December 2016
  116. LEE CF, Wang YC, Cheng CH, Wu TH, et al
    Application of CD8+ Cells Count as a Guide of Immunosuppressive Regimen Introduction for Very Sick Patients Undergoing Liver Transplantation.
    Transplant Proc. 2016;48:3356-3361.
    PubMed     Text format     Abstract available


  117. MIZUNO Y, Ito S, Hattori K, Nagaya M, et al
    Changes in Muscle Strength and Six-Minute Walk Distance Before and After Living Donor Liver Transplantation.
    Transplant Proc. 2016;48:3348-3355.
    PubMed     Text format     Abstract available


  118. BAKULA A, Pawlowska J, Niewiadomska O, Jankowska I, et al
    Liver Transplantation in Polish Children With alpha1-Antitrypsin Deficiency: A Single-Center Experience.
    Transplant Proc. 2016;48:3323-3327.
    PubMed     Text format     Abstract available


  119. REAL C, Sobreira Fernandes D, Sa Couto P, Correia de Barros F, et al
    Survival Predictors in Liver Transplantation: Time-Varying Effect of Red Blood Cell Transfusion.
    Transplant Proc. 2016;48:3303-3306.
    PubMed     Text format     Abstract available


  120. SIBULESKY L, Hansen RN, Leca N, Blosser C, et al
    Landscape of Kidney Transplantation in Patients With Compensated Liver Disease: Results of a Survey of Transplant Surgeons in the United States.
    Transplant Proc. 2016;48:3268-3273.
    PubMed     Text format     Abstract available


    November 2016
  121. SULIK-TYSZKA B, Figiel W, Krawczyk M, Wroblewska M, et al
    Invasive Aspergillosis of the Stomach and Co-infection With Candida krusei in a Patient With Terminal Liver Failure: A Case Report.
    Transplant Proc. 2016;48:3149-3152.
    PubMed     Text format     Abstract available


  122. MOLINA AR, Vilchez AR, Dominguez MB, Garcia AN, et al
    Influence of Body Mass Index on Venous Thrombotic Complications of Liver Transplants.
    Transplant Proc. 2016;48:3017-3020.
    PubMed     Text format     Abstract available


  123. GARCIA-PAJARES F, Penas-Herrero I, Sanchez-Ocana R, Torrres-Yuste R, et al
    Metabolic Syndrome After Liver Transplantation: Five-Year Prevalence and Risk Factors.
    Transplant Proc. 2016;48:3010-3012.
    PubMed     Text format     Abstract available


  124. FUJII MH, Gierlach J, Alami S, Ericksen C, et al
    Case Report Demonstrating the Safe and Effective Means of Expanding the Donor Pool With Livers Recovered From Brain-Dead Donors After Ethylene Glycol Toxicity.
    Transplant Proc. 2016;48:3064-3066.
    PubMed     Text format     Abstract available


  125. TABRIZIAN P, Joseph TT, Radkani P, Cohen E, et al
    Liver Transplantation in an Adult Recipient With Situs Inversus Totalis: Case Report and Review of the Literature.
    Transplant Proc. 2016;48:3163-3166.
    PubMed     Text format     Abstract available


  126. RABELO AV, Bastante MD, Raya AM, Mendez CS, et al
    Liver Transplantation Results by Donor Age.
    Transplant Proc. 2016;48:2994-2996.
    PubMed     Text format     Abstract available


  127. SAN SEGUNDO D, Alonso C, Ruiz P, Roman I, et al
    De Novo Donor-Specific Anti-Human Leukocyte Antigen Antibody Detection in Long-Term Adult Liver Transplantation.
    Transplant Proc. 2016;48:2980-2982.
    PubMed     Text format     Abstract available


  128. SAN SEGUNDO D, Ruiz P, Irure J, Arias-Loste MT, et al
    Serum Levels of Interleukin-34 During Acute Rejection in Liver Transplantation.
    Transplant Proc. 2016;48:2977-2979.
    PubMed     Text format     Abstract available


  129. TINOCO-GONZALEZ J, Suarez-Artacho G, Bernal-Bellido C, Cepeda-Franco C, et al
    Analysis of the First 1000 Liver Transplants in Virgen del Rocio Hospital.
    Transplant Proc. 2016;48:2973-2976.
    PubMed     Text format     Abstract available


    September 2016
  130. MARQUES DM, Teixeira HR, Lopes AR, Martins-Pedersoli TA, et al
    Sleep Quality Assessment and Daytime Sleepiness of Liver Transplantation Candidates.
    Transplant Proc. 2016;48:2356-2360.
    PubMed     Text format     Abstract available


  131. ANNUNZIATA TB, Paulino K, Fernandes R, Bento G, et al
    Impact of Model for End-stage Liver Disease Score in Post-Liver Transplantation Prognosis.
    Transplant Proc. 2016;48:2348-2351.
    PubMed     Text format     Abstract available


  132. PEREIRA S, Cruz CM, Soares M, Gandara J, et al
    Histology Utility in Liver Graft Surveillance: What About Normal Liver Tests?
    Transplant Proc. 2016;48:2344-2347.
    PubMed     Text format     Abstract available


    July 2016
  133. DENG L, Kong X, Liu G, Li C, et al
    Transplantation of Adipose-Derived Mesenchymal Stem Cells Efficiently Rescues Thioacetamide-Induced Acute Liver Failure in Mice.
    Transplant Proc. 2016;48:2208-15.
    PubMed     Text format     Abstract available


    June 2016
  134. GOJOWY D, Adamczak M, Dudzicz S, Gazda M, et al
    High Frequency of Arterial Hypertension in Patients After Liver Transplantation.
    Transplant Proc. 2016;48:1721-4.
    PubMed     Text format     Abstract available


  135. SULIMA M, Wolyniec W, Oladakowska-Jedynak U, Patkowski W, et al
    Liver Transplantation for Incurable Alveolar Echinococcosis: An Analysis of Patients Hospitalized in Department of Tropical and Parasitic Diseases in Gdynia.
    Transplant Proc. 2016;48:1708-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: